Astrazeneca (AZN) Change in Taxes (2009 - 2026)

Astrazeneca has reported Change in Taxes for 18 years, with the latest figure at -$1.5 billion in Q2 2026.

• On a quarterly basis, Change in Taxes fell 28.58% year-over-year to -$1.5 billion in Q2 2026; TTM through Jun 2026 was -$3.3 billion, a 13.0% decrease from a year earlier, with the FY2025 full-year figure at -$2.8 billion, down 3.45% from the prior year.
• Change in Taxes was -$1.5 billion for Q2 2026 at Astrazeneca, down from -$526.0 million in the prior quarter.
• The five-year high for Change in Taxes was -$225.0 million in Q1 2023, with the low at -$1.5 billion in Q2 2026.
• Average Change in Taxes over 5 years is -$693.8 million, with a median of -$648.0 million recorded in 2025.
• The sharpest annual moves came in 2022 and 2024: Change in Taxes jumped 31.33% in 2022, then tumbled 91.11% in 2024.
• Over 5 years, Change in Taxes stood at -$778.0 million in 2022, then retreated by 7.46% to -$836.0 million in 2023, then advanced by 7.66% to -$772.0 million in 2024, then climbed by 15.54% to -$652.0 million in 2025, then tumbled by 133.9% to -$1.5 billion in 2026.
• The last three Change in Taxes figures came in at -$1.5 billion (Q2 2026), -$526.0 million (Q1 2026), and -$652.0 million (Q4 2025), per Business Quant data.